NEW
Lynparza

Lynparza Description

Manufacturer:

AstraZeneca

Distributor:

Zuellig Pharma
Full Prescribing Info
Description
Lynparza 100 mg film-coated tablets: Yellow to dark yellow, oval, bi-convex tablet, debossed with 'OP100' on one side and plain on the other side.
Each film-coated tablet contains 100 mg olaparib.
Lynparza 150 mg film-coated tablets: Green to green/grey, oval, bi-convex tablet, debossed with 'OP150' on one side and plain on the other side.
Each film-coated tablet contains 150 mg olaparib.
Excipient with known effect: This medicinal product contains 0.24 mg sodium per 100 mg tablet and 0.35 mg sodium per 150 mg tablet, i.e. essentially "sodium-free".
Excipients/Inactive Ingredients: Tablet core: Copovidone, Colloidal anhydrous silica, Mannitol, Sodium stearyl fumarate.
Tablet coating: Hypromellose, Macrogol 400, Titanium dioxide (E171), Iron oxide yellow (E172), Iron oxide black (E172) (150 mg tablets only).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in